Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,128
Closed -$211K 565
2019
Q3
$211K Sell
2,128
-267
-11% -$25.4K 0.02% 215
2019
Q2
$221K Buy
2,395
+267
+13% +$25.4K 0.02% 217
2019
Q1
$201K Sell
2,128
-123
-5% -$10.8K 0.02% 214
2018
Q4
$144K Sell
2,251
-70
-3% -$5.17K 0.02% 232
2018
Q3
$208K Buy
2,321
+119
+5% +$10.5K 0.02% 205
2018
Q2
$175K Sell
2,202
-159
-7% -$13.2K 0.02% 209
2018
Q1
$211K Buy
2,361
+1,926
+443% +$185K 0.02% 197
2017
Q4
$45K Sell
435
-348
-44% -$39.3K ﹤0.01% 317
2017
Q3
$114K Sell
783
-198
-20% -$27K 0.01% 231
2017
Q2
$127K Buy
981
+159
+19% +$19.5K 0.01% 226
2017
Q1
$102K Buy
822
+620
+307% +$74.2K 0.01% 230
2016
Q4
$23K Sell
202
-158
-44% -$17.6K ﹤0.01% 402
2016
Q3
$38K Buy
360
+158
+78% +$17.1K ﹤0.01% 327
2016
Q2
$20K Hold
202
﹤0.01% 350
2016
Q1
$20K Hold
202
﹤0.01% 347
2015
Q4
$24K Hold
202
﹤0.01% 328
2015
Q3
$22K Hold
202
﹤0.01% 359
2015
Q2
$23K Hold
202
﹤0.01% 353
2015
Q1
$23K Buy
202
+74
+58% +$8.84K ﹤0.01% 345
2014
Q4
$14K Hold
128
﹤0.01% 416
2014
Q3
$12K Buy
128
+64
+100% +$5.78K ﹤0.01% 446
2014
Q2
$5K Sell
64
-64
-50% -$4.87K ﹤0.01% 545
2014
Q1
$9K Hold
128
﹤0.01% 464
2013
Q4
$11K Hold
128
﹤0.01% 447
2013
Q3
$10K Hold
128
﹤0.01% 450
2013
Q2
$7K Buy
+128
New +$7.7K ﹤0.01% 512

Other funds holding CELG

MOTCO's CELG Position: Q4 2019 in Review

MOTCO sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,128 shares — an estimated $211K sold.

MOTCO first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $221K in Q2 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • MOTCO reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • MOTCO sold 2,128 Celgene Corp shares in Q4 2019, an estimated $211K.
  • MOTCO first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • MOTCO's Celgene Corp position peaked at $221K in Q2 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on MOTCO's 13F filing for Q4 2019, filed 6 Feb 2020.